Patent Assignment
Reel/Frame 018516/0995
Change of Name
Recorded: 2006-11-10
Pages: 4
Assignor
SYN X PHARMA INC.
Executed: 2006-02-09
Assignee
NANOGEN POINT CARE, INC.
1 MARMAC DRIVE, TORONTO, ONTARIO, M9W 1E7, CANADA
Covered Property
(1)
Fibronectin Biopolymer Markers Indicative of Type Ii Diabetes
Application:
09/991,796 →
Publication:
US 2003/0100010
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 19, 2002
From: JACKOWSKI, GEORGE; MARSHALL, JOHN
To: SYN X PHARMA
Reel/Frame 012656/0599 →
Security Agreement
Jul 18, 2003
From: SYNX PHARMA INC.
To: CANADA TRUST COMPANY, THE
Reel/Frame 014242/0790 →
Security Interest
Feb 12, 2004
From: SYNX PHARMA INC.
To: NANOGEN, INC.
Reel/Frame 014337/0010 →
Assignment of Assignor's Interest
Nov 13, 2006
From: NANOGEN POINT OF CARE INC.
To: NANOGEN INC.
Reel/Frame 018521/0373 →
Assignment of Intellectual Property Security Agreement
Apr 15, 2008
From: THE CANADA TRUST COMPANY
To: NANOGEN, INC.
Reel/Frame 020807/0247 →
Release of Security Interest
Apr 17, 2008
From: NANOGEN POINT OF CARE, INC.
To: NANOGEN, INC.
Reel/Frame 020826/0087 →
Grant of Security Interest
Jul 25, 2008
From: NANOGEN, INC.
To: PORTSIDE GROWTH & OPPORTUNITY FUND, AS COLLATERAL AGENT
Reel/Frame 021291/0605 →